At the start of 2026, conversations in the tech world are shifting from what can be built to how fast new solutions can be implemented and scaled. 3M plays a critical role in this global ecosystem and is working to bridge the “innovation gap” — the space where digital potential m
Global energy consumption for mobile networks is a hot topic. Carbon footprint and costs generated by energy use is one of our industry’s greatest challenges.
NortonLifeLock and NASSCOM Foundation in India partner on the Cyber Security Skills Development Initiative for Women. The program is designed to create greater opportunities for female engineering grads by equipping them with in-demand job skills.
Learn how Johnson & Johnson sites are improving how and when we get the healthcare products and services we need and serving as a beacon to other manufacturers worldwide.
Illumina Inc. (NASDAQ: ILMN) today announced a partnership with Boehringer Ingelheim to develop companion diagnostics (CDx) for several programs in Boehringer Ingelheim's oncology pipeline. The partnership aims to accelerate the development of therapy selection and precision medicines for patients with advanced cancer.
Illumina, Inc. (NASDAQ: ILMN) today announced a multi-year partnership with Agendia N.V., a world leader in precision oncology for breast cancer, to co-develop in vitro diagnostic (IVD) tests for oncology testing. The partnership is intended to advance the use of next-generation sequencing (NGS) for decentralized oncology testing and aligns with Illumina's approach to IVD partnerships in oncology. Agendia joins Illumina's growing portfolio of more than 30 IVD partners developing over 40 sequencing-based solutions for cancer prognosis, therapy selection and other applications.
Illumina, Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC), today announced a multi-year agreement to accelerate medicines development through large-scale genomics and the establishment of a preeminent clinico-genomic resource. Using Illumina's next-generation sequencing (NGS) platforms, scientists and researchers will be able to better identify disease associations and targets for intervention by analyzing data derived from VUMC's extensive, high-quality biobank of approximately 250,000 de-identified human DNA samples and associated longitudinal, structured medical data.
Illumina, Inc. (NASDAQ:ILMN) Chief Executive Officer, Francis deSouza, discussed the company's strong growth trajectory, including 2021 results and 2022 guidance. deSouza also announced new partnerships and technologies that will advance the company's mission of improving human health by unlocking the power of the genome.
Lori Shaffer, the vice president of Kimberly-Clark’s global nonwovens business and a mother of three young children, is a mechanical engineer who has devoted her career to driving sustainability through materials science
Over the past year at AMD, we engaged our stakeholders to listen to their input and refresh our strategic focus areas in ESG - driving value for our employees, customers, suppliers, shareholders and communities.
The fully autonomous vehicles of the not-so-distant future promise tremendous gains in automotive safety and transportation efficiency. But to fulfill this promise, automotive OEMs must move beyond contemporary levels of vehicle autonomy.
Cascale shares updates on its strategic partnerships with industry stakeholders geared toward shifting the industry into one that gives back more than...
The business landscape is reorienting itself and you can almost hear priorities shifting toward change-readiness and the bigger picture. And in this...
